Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Verschillende progestagenen verhogen risico op intracraniaal meningeoom
jul 2024 | Neuro-oncologie